Dashboard
Manage Tickers

VCVISTEON CORP

Nasdaq visteon.com


$ 112.16 $ 2.53 (2.31 %)    

Friday, 26-Apr-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 112.19
$ 110.79
$ 0.00 x 0
$ 0.00 x 0
$ 110.79 - $ 114.16
$ 105.19 - $ 159.87
439,424
na
3.1B
$ 1.32
$ 6.27
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-20-2024 12-31-2023 10-K
3 10-26-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-16-2023 12-31-2022 10-K
7 10-27-2022 09-30-2022 10-Q
8 07-28-2022 06-30-2022 10-Q
9 04-28-2022 03-31-2022 10-Q
10 02-17-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 07-29-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 02-18-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 07-30-2020 06-30-2020 10-Q
17 04-30-2020 03-31-2020 10-Q
18 02-20-2020 12-31-2019 10-K
19 10-24-2019 09-30-2019 10-Q
20 07-25-2019 06-30-2019 10-Q
21 04-25-2019 03-31-2019 10-Q
22 02-21-2019 12-31-2018 10-K
23 10-25-2018 09-30-2018 10-Q
24 07-26-2018 06-30-2018 10-Q
25 04-26-2018 03-31-2018 10-Q
26 02-22-2018 12-31-2017 10-K
27 10-26-2017 09-30-2017 10-Q
28 07-27-2017 06-30-2017 10-Q
29 04-27-2017 03-31-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 10-27-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 04-28-2016 03-31-2016 10-Q
34 02-25-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 02-26-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-06-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

what-8-analyst-ratings-have-to-say-about-visteon
What 8 Analyst Ratings Have To Say About V...
04/26/2024 20:02:00

visteon-analysts-cut-their-forecasts-after-weak-earnings
Visteon Analysts Cut Their Forecasts After...
04/26/2024 12:25:14

baird-maintains-outperform-on-visteon-lowers-price-target-to-137
Baird Maintains Outperform on Visteon, Low...
04/26/2024 12:15:13

Baird analyst Luke Junk maintains Visteon (NASDAQ:VC) with a Outperform and lowers the price target from $140 to $137.

wells-fargo-upgrades-visteon-to-equal-weight-raises-price-target-to-108
Wells Fargo Upgrades Visteon to Equal-Weig...
04/26/2024 11:02:21

Wells Fargo analyst Colin Langan upgrades Visteon (NASDAQ:VC) from Underweight to Equal-Weight and raises the price target f...

visteon-maintains-full-year-2024-guidance-and-anticipates-sales-of-40b-42b-est-4105b
Visteon Maintains Full-Year 2024 Guidance ...
04/25/2024 11:03:23

Visteon is maintaining its full-year 2024 guidance and anticipates adjusted EBITDA in the range of $470 to $500 million, and ad...

visteon-q1-2024-adj-eps-161-misses-168-estimate-sales-933000m-miss-977869m-estimate
Visteon Q1 2024 Adj EPS $1.61 Misses $1.68...
04/25/2024 10:56:48

Visteon (NASDAQ:VC) reported quarterly earnings of $1.61 per share which missed the analyst consensus estimate of $1.68 by 4.17...

jp-morgan-maintains-neutral-on-visteon-lowers-price-target-to-145
JP Morgan Maintains Neutral on Visteon, Lo...
04/22/2024 14:08:14

JP Morgan analyst Ryan Brinkman maintains Visteon (NASDAQ:VC) with a Neutral and lowers the price target from $146 to $145.

guggenheim-maintains-buy-on-visteon-lowers-price-target-to-126
Guggenheim Maintains Buy on Visteon, Lower...
04/17/2024 17:06:49

Guggenheim analyst Ronald Jewsikow maintains Visteon (NASDAQ:VC) with a Buy and lowers the price target from $136 to $126.

forecasting-the-future-7-analyst-projections-for-visteon
Forecasting The Future: 7 Analyst Projecti...
04/10/2024 15:01:19

barclays-upgrades-visteon-to-overweight-raises-price-target-to-145
Barclays Upgrades Visteon to Overweight, R...
04/10/2024 14:54:50

Barclays analyst Brian Johnson upgrades Visteon (NASDAQ:VC) from Equal-Weight to Overweight and raises the price target from...

rbc-capital-maintains-outperform-on-visteon-lowers-price-target-to-146
RBC Capital Maintains Outperform on Visteo...
03/07/2024 14:54:01

RBC Capital analyst Tom Narayan maintains Visteon (NASDAQ:VC) with a Outperform and lowers the price target from $188 to $146.

b-of-a-securities-maintains-buy-on-visteon-lowers-price-target-to-160
B of A Securities Maintains Buy on Visteon...
02/29/2024 15:12:36

B of A Securities analyst John Murphy maintains Visteon (NASDAQ:VC) with a Buy and lowers the price target from $165 to $160.

evaluating-visteon-insights-from-6-financial-analysts
Evaluating Visteon: Insights From 6 Financ...
02/21/2024 19:00:56

visteon-q4-revenues-dip-7-issues-fy24-revenue-outlook-below-estimates
Visteon Q4 Revenues Dip 7%, Issues FY24 Re...
02/20/2024 17:21:06

Visteon Corporation's Q4 revenues decline 7%, with FY24 outlook below estimates, despite strong operating performance and n...

us-stocks-set-for-weaker-open-on-mixed-retail-earnings-but-analyst-shrugs-off-weakness-as-scary-moments-in-great-years
US Stocks Set For Weaker Open On Mixed Ret...
02/20/2024 12:40:09

The market is entering a typically soft period and inflation worries have weighed on sentiment this time around.

visteon-expects-fy24-net-sales-of-4b-42b-projects-adjusted-ebitda-in-the-range-of-470m-500m
Visteon Expects FY24 Net Sales Of $4B-$4.2...
02/20/2024 12:04:44

visteon-q4-adj-eps-191-misses-209-estimate-sales-99000m-miss-105b-estimate
Visteon Q4 Adj. EPS $1.91 Misses $2.09 Est...
02/20/2024 12:02:23

Visteon (NASDAQ:VC) reported quarterly earnings of $1.91 per share which missed the analyst consensus estimate of $2.09 by 8.61...

earnings-scheduled-for-february-20-2024
Earnings Scheduled For February 20, 2024
02/20/2024 11:52:12

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue...

earnings-outlook-for-visteon
Earnings Outlook For Visteon
02/19/2024 14:01:58

where-visteon-stands-with-analysts
Where Visteon Stands With Analysts
01/25/2024 13:00:16

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION